| Literature DB >> 16202063 |
B B D Koate1, F I Buseri, Z A Jeremiah.
Abstract
Anti-HCV pre-transfusion testing among blood donors has not been introduced as a mandatory test in Rivers State, hence the risk of transfusion-transmitted HCV cannot be fully ascertained. One thousand (1000) apparently healthy blood donors were screened using a rapid second - generation test, the HEP C SPOT HCV assay. An overall prevalence of 2.9% was observed in this study. The highest prevalence (8.1%) was found among adults aged between 26 and 33 years and commercial donors.Entities:
Mesh:
Year: 2005 PMID: 16202063 DOI: 10.1111/j.1365-3148.2005.00601.x
Source DB: PubMed Journal: Transfus Med ISSN: 0958-7578 Impact factor: 2.019